Boudewijn van Vliet

Antion Biosciences SA is a Swiss-based biotechnology company that develops universal cell and gene therapy products to treat diseases with significant unmet medical needs. The private company is based in Geneva, Switzerland. The company's proprietary gene silencing and co-expression gene constructs allow for a modular and tunable approach to multiplex engineering of therapeutic cells. Antion aims to develop off-the-shelf therapies with enhanced potency and improved safety to make cell and gene therapies universal and broaden access to these life-changing therapies for all patients. Antion Biosciences was founded by Michael Pepper and Roberto Speck, and the CEO is Marco Alessandrini.

SIX SIS Ltd. operates as the national central securities depository of the Swiss financial market and an international central securities depository. It offers services for the settlement and custody of national and international securities. The firm also operates an online real-time settlement system, which enables market participants to settle their transactions through a single technical interface. The company was founded on May 21, 1999 and is headquartered in Olten, Switzerland.